Skip to main content

Advertisement

Table 3 Proportions of statin prescription in bivariate analysis.

From: Patterns and predictors of statin prescription in patients with type 2 diabetes

Characteristic Primary prevention Secondary prevention
  Percent statin use Percent statin use
Number n = 27,322
18.5%
n = 17,571
38.1%
Sex   
   Male 18.5% 41.3%
   Female 18.5% 34.4%
Age (years)   
   <40 11.7% 37.8%
   ≥40 and <50 14.7% 43.3%
   ≥50 and <60 18.9% 43.3%
   ≥60 and <70 21.2% 43.3%
   ≥70 and <80 17.9% 36.8%
   ≥80 11.7% 21.9%
Age at diagnosis of diabetes (years)   
   <45 16.6% 44.8%
   ≥45 and <55 19.0% 42.1%
   ≥55 and <65 20.5% 41.0%
   ≥65 16.4% 31.8%
Diabetes duration (years)   
   <1 11.4% 37.9%
   ≥1 and <5 19.3% 39.2%
   ≥5 and <10 18.9% 38.0%
   ≥10 20.2% 37.1%
Body mass index (kg/m 2 )   
   <25 16.5% 33.0%
   ≥25 and <30 19.3% 39.1%
   ≥30 and <35 19.1% 40.7%
   ≥35 16.9% 37.6%
Smoking status   
   Never smoker 18.1% 35.2%
   Former smoker 20.1% 44.8%
   Current smoker 18.5% 36.0%
Hypertension   
   no 11.7% 22.9%
   yes 19.9% 39.0%
HbA1c (%)   
   <6.5 17.8% 36.9%
   ≥6.5 and <7.5 19.2% 39.8%
   ≥7.5 and <8.5 18.8% 36.7%
   ≥8.5 17.6% 38.5%
Albuminuria   
   No albuminuria 17.4% 37.4%
Albuminuria
(≥20 mg/l)
19.0% 39.1%
Lipoprotein concentrations (mg/dl)   
   Total cholesterol   
<200 19.9% 47.2%
≥200 and <240 16.2% 34.8%
≥240 19.7% 32.6%
   LDL cholesterol   
<100 23.8% 54.9%
≥100 and <130 19.7% 42.0%
≥130 and <160 16.9% 32.0%
≥160 19.0% 30.9%
   HDL cholesterol   
<40 (M) or <50 (F) 19.9% 38.2%
≥40 (M) or ≥50 (F) 19.1 39.9%
   Triglycerides   
<150 9.8% 37.3%
≥150 and <400 20.0% 38.9%
≥400 22.9% 45.4%
Estimated 5-year cardiovascular risk (%)   
   <5 6.6%  
   ≥5 and <10 13.9%  
   ≥10 and <15 19.7%  
   ≥15 and <20 23.4%  
   ≥20 and <25 23.9%  
   ≥25 and <30 26.9%  
   ≥30 26.9%  
Atherosclerotic complications   
   Coronary heart disease   40.1%
   Cerebrovascular disease   37.3%
   Peripheral arterial occlusive disease   38.0%
  1. Subjects were stratified according to primary or secondary prevention and groups were analyzed separately. Confidence intervals and odds ratios for receiving a statin can be obtained from Additional file 1.